Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Seroconverter Specimen Panels for Validation of Incidence Assays, Contract Solicitation 2004-N-01329

---
identifier: "/us/fr/04-15504"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Seroconverter Specimen Panels for Validation of Incidence Assays, Contract Solicitation 2004-N-01329"
title_number: 0
title_name: "Federal Register"
section_number: "04-15504"
section_name: "Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Seroconverter Specimen Panels for Validation of Incidence Assays, Contract Solicitation 2004-N-01329"
positive_law: false
currency: "2004-07-08"
last_updated: "2004-07-08"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "04-15504"
document_type: "notice"
publication_date: "2004-07-08"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "69 FR 41267"
fr_volume: 69
---


#  Disease, Disability, and Injury Prevention and Control; Special Emphasis Panel (SEP): Seroconverter Specimen Panels for Validation of Incidence Assays, Contract Solicitation 2004-N-01329

In accordance with section 10(a)(2) of the Federal Advisory; Committee Act (Pub. L. 92-463), the Centers for Disease; Control and Prevention (CDC) announces the following meeting:

*Name:* Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Seroconverter Specimen Panels for Validation of Incidence Assays, Contract Solicitation 2004-N-01329.

*Times and Dates:* 1 p.m.-1:45 p.m., July 23, 2004 (Open).

1:45 p.m.-3 p.m., July 23, 2004 (Closed).

*Place:* Teleconference number 1-888-396-9924, pass code 21864.

*Status:* Portions of the meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.

*Matters to be Discussed:* The meeting will include the review, discussion, and evaluation of applications received in response to Contract Solicitation 2004-N-01329.

*Contact Person for More Information:* Noreen L. Qualls, DrPH, Scientific Review Administrator, CDC, National Center for HIV, STD, and TB Prevention, Office of the Associate Director of Science, 1600 Clifton Road, NE., MS-E07, Atlanta, GA 30333, Telephone (404) 639-8006.

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: June 29, 2004.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).